Suppr超能文献

2020 年 8 月至 2021 年 7 月期间 SARS-CoV-2 变异株的地理流行情况。

Geographical prevalence of SARS-CoV-2 variants, August 2020 to July 2021.

机构信息

Department of Pathology, Hong Kong Sanatorium and Hospital, Happy Valley, Hong Kong, China.

出版信息

Sci Rep. 2022 Mar 18;12(1):4704. doi: 10.1038/s41598-022-08684-1.

Abstract

We extracted one-year genomic data (August 2020-July 2021) from GISAID EpiCoV™ database and estimated monthly proportions of 11 SARS-CoV-2 variants in various geographical regions. From continental perspective, Delta VOC predominated in Africa, Asia, Europe, North America and Oceania, with proportions of 67.58-98.31% in July 2021. In South America, proportion of Delta VOC (23.24%) has been approaching the predominant yet diminishing Gamma VOC (56.86%). We further analyzed monthly data on new COVID-19 cases, new deaths, vaccination status and variant proportions of 6 countries. Delta VOC predominated in all countries except Brazil (Gamma VOC) in July 2021. In most occasions, rise and predominance of Alpha, Beta, Gamma, Delta and Zeta variants were accompanied with surges of new cases, especially after the time point of major lineage interchange. The ascending phases of new cases lasted for 1-5 months with 1.69- to 40.63-fold peak growth, whereas new death tolls varied with regional vaccination status. Our data suggested surges of COVID-19 cases might be predicted from variant surveillance data. Despite vaccine breakthroughs by Delta VOC, death tolls were more stable in countries with better immunization coverage. Another takeaway is the urgent need to improve vaccine efficacy against Delta and emerging variants.

摘要

我们从 GISAID EpiCoV™ 数据库中提取了一年(2020 年 8 月至 2021 年 7 月)的基因组数据,并估计了不同地理区域中 11 种 SARS-CoV-2 变体的月度比例。从大陆角度来看,Delta VOC 在非洲、亚洲、欧洲、北美和大洋洲占主导地位,2021 年 7 月的比例为 67.58%-98.31%。在南美洲,Delta VOC 的比例(23.24%)已接近占主导地位但逐渐减少的 Gamma VOC(56.86%)。我们进一步分析了 6 个国家的每月新 COVID-19 病例、新死亡、疫苗接种情况和变体比例数据。2021 年 7 月,除巴西(Gamma VOC)外,所有国家均以 Delta VOC 为主导。在大多数情况下,Alpha、Beta、Gamma、Delta 和 Zeta 变体的上升和主导地位伴随着新病例的激增,尤其是在主要谱系交换后。新病例的上升阶段持续了 1-5 个月,峰值增长率为 1.69 至 40.63 倍,而新死亡人数则因地区疫苗接种情况而异。我们的数据表明,新的 COVID-19 病例可能可以通过变体监测数据来预测。尽管 Delta VOC 疫苗突破性感染有所增加,但疫苗接种率较高的国家的死亡人数更为稳定。另一个重要启示是,迫切需要提高针对 Delta 和新兴变体的疫苗效力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e158/8933550/57aaf20a14e1/41598_2022_8684_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验